Drug · DIN 02469332
CUVPOSA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 1, 2022; first marketed April 3, 2018.
- Drug Identification Number (DIN)
- 02469332
- Company (DIN owner)
- Medexus Pharmaceuticals Inc.Bolton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Oral
- Therapeutic class (ATC)
- Glycopyrronium A03AB02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GLYCOPYRROLATE | 1 MG | 5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 1, 2022: NOC 29358New Drug Submission (NDS) · Administrative: Change in Product Ownership
- April 20, 2020: NOC 23485New Drug Submission (NDS) · Merger - buyout
- October 30, 2017: NOC 19979New Drug Submission (NDS)